Total Value
$5935.68B
Holdings Count
64
Period of Report
Jun 30, 2025
Report Type
HR
| Issuer | CUSIP | Value | Shares |
|---|---|---|---|
| ASCENDIS PHARMA A/S - ADR | 04351P101 | $1774.59B | 10,281,496 |
| VAXCYTE INC | 92243G108 | $389.01B | 11,965,991 |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | $351.42B | 5,561,359 |
| JANUX THERAPEUTICS INC | 47103J105 | $258.48B | 11,189,693 |
| AVIDITY BIOSCIENCES INC | 05370A108 | $206.36B | 7,266,031 |
| ARCELLX INC | 03940C100 | $199.96B | 3,036,527 |
| 89BIO INC | 282559103 | $195.32B | 19,889,683 |
| ARS PHARMACEUTICALS INC | 82835W108 | $189.52B | 10,860,977 |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | $183.62B | 10,138,938 |
| SIONNA THERAPEUTICS INC | 829401108 | $181.23B | 10,445,322 |
| CIDARA THERAPEUTICS INC | 171757206 | $163.93B | 3,365,523 |
| EDGEWISE THERAPEUTICS INC | 28036F105 | $129.82B | 9,902,633 |
| LENZ THERAPEUTICS INC | 52635N103 | $122.48B | 4,178,823 |
| WAVE LIFE SCIENCES LTD | Y95308105 | $118.31B | 18,202,009 |
| TYRA BIOSCIENCES INC | 90240B106 | $116.74B | 12,198,625 |
| GH RESEARCH PLC | G3855L106 | $93.58B | 7,676,697 |
| DYNE THERAPEUTICS INC | 26818M108 | $92.48B | 9,714,392 |
| GERON CORP | 374163103 | $85.13B | 60,379,366 |
| DISC MEDICINE INC | 254604101 | $83.52B | 1,577,106 |
| MINERALYS THERAPEUTICS INC | 603170101 | $83.17B | 6,147,280 |
| SEPTERNA INC | 81734D104 | $73.95B | 6,995,858 |
| FULCRUM THERAPEUTICS INC | 359616109 | $70.38B | 10,229,099 |
| BICARA THERAPEUTICS INC | 055477103 | $64.62B | 6,955,993 |
| VOR BIOPHARMA INC | 929033108 | $64.23B | 39,646,039 |
| TAYSHA GENE THERAPIES INC | 877619106 | $54.41B | 23,555,648 |
| DIANTHUS THERAPEUTICS INC | 252828108 | $53.41B | 2,866,733 |
| RXSIGHT INC | 78349D107 | $48.14B | 3,702,967 |
| TOURMALINE BIO INC | 89157D105 | $40.60B | 2,538,925 |
| SCHOLAR ROCK HOLDING CORP | 80706P103 | $40.25B | 1,136,453 |
| CLIMB BIO INC | 28658R106 | $35.88B | 28,939,395 |
| STRUCTURE THERAPEUTICS INC | 86366E106 | $31.47B | 1,517,418 |
| SOLID BIOSCIENCES INC | 83422E204 | $28.30B | 5,811,323 |
| METSERA INC | 59267L107 | $19.22B | 675,525 |
| MONOPAR THERAPEUTICS INC | 61023L207 | $18.29B | 511,207 |
| NKARTA INC | 65487U108 | $17.94B | 10,805,129 |
| LARIMAR THERAPEUTICS INC | 517125100 | $17.47B | 6,045,351 |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | $17.32B | 14,932,063 |
| ENLIVEN THERAPEUTICS INC | 29337E102 | $17.03B | 848,986 |
| TRAVERE THERAPEUTICS INC | 89422G107 | $17.02B | 1,150,000 |
| 4D MOLECULAR THERAPEUTICS IN | 35104E100 | $16.93B | 4,563,211 |
| HINGE HEALTH INC-A | 433313103 | $15.53B | 300,000 |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | $14.88B | 9,853,302 |
| PEPGEN INC | 713317105 | $11.87B | 10,689,545 |
| JADE BIOSCIENCES INC | 008064206 | $10.61B | 1,062,326 |
| TANGO THERAPEUTICS INC | 87583X109 | $10.24B | 2,000,000 |
| ACRIVON THERAPEUTICS INC | 004890109 | $9.93B | 8,340,508 |
| ELEDON PHARMACEUTICALS INC | 28617K101 | $9.66B | 3,566,338 |
| ARCUS BIOSCIENCES INC | 03969F109 | $9.25B | 1,136,364 |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | $7.96B | 750,000 |
| OMADA HEALTH INC | 68170A108 | $7.32B | 400,000 |
| WEREWOLF THERAPEUTICS INC | 95075A107 | $7.28B | 6,681,307 |
| BETA BIONICS INC | 08659B102 | $7.28B | 500,000 |
| CYTOMX THERAPEUTICS INC | 23284F105 | $6.04B | 2,661,331 |
| 10X GENOMICS INC-CLASS A | 88025U109 | $5.50B | 475,343 |
| SURROZEN INC | 86889P208 | $5.39B | 602,626 |
| GENEDX HOLDINGS CORP | 81663L200 | $5.36B | 58,044 |
| AVALO THERAPEUTICS INC | 05338F306 | $4.66B | 932,973 |
| ADICET BIO INC | 007002108 | $4.60B | 7,541,000 |
| MBX BIOSCIENCES INC | 55287L101 | $4.31B | 377,841 |
| PROTARA THERAPEUTIC INC | 74365U107 | $3.15B | 1,039,295 |
| CLIMB BIO INC | 28658R106 | $3.08B | 2,479,872 |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | $2.67B | 333,333 |
| ACADIA HEALTHCARE CO INC | 00404A109 | $2.03B | 89,262 |
| INFLARX NV | N44821101 | $1.56B | 1,973,233 |